Serum amyloid a induces a vascular smooth muscle cell phenotype switch through the p38 MAPK signaling pathway

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Zhang, Xincai ^a   Chen, Jinqin ^a   Wang, Shixun ^a  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; CELLULAR RETINOL BINDING PROTEIN 1; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SERUM AMYLOID A; STRESS ACTIVATED PROTEIN KINASE; TRANSGELIN; ACUTE PHASE PROTEIN; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEDIFFERENTIATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ATHEROSCLEROSIS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MAPK SIGNALING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; VASCULAR SMOOTH MUSCLE;

ACUTE-PHASE PROTEINS; ANIMALS; ATHEROSCLEROSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PYRIDINES; RATS; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 85021652172     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/4941379     Document Type: Article

References (27)

1. P. Libby, "Inflammation in atherosclerosis, " Nature, vol. 420, no. 6917, pp. 868-874, 2002.
2. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis, " Nature, vol. 473, no. 7347, pp. 317-325, 2011.
3. A. C. Doran, N. Meller, and C. A. McNamara, "Role of smooth muscle cells in the initiation and early progression of atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812-819, 2008.
4. G. K. Owens, M. S. Kumar, and B. R. Wamhoff, "Molecular regulation of vascular smooth muscle cell differentiation in development and disease, " Physiological Reviews, vol. 84, no. 3, pp. 767-801, 2004.
5. Y. Xie, Y. Jin, B. L. Merenick, et al., "Phosphorylation of GATA-6 is required for vascular smooth muscle cell differentiation after mTORC1 inhibition, " Science Signaling, vol. 8, no. 376, articleno. ra44, 2015.
6. D. Gomez, and G. K. Owens, "Smooth muscle cell phenotypic switching in atherosclerosis, " Cardiovascular Research, vol. 95, no. 2, pp. 156-164, 2012.
7. S. Urieli-Shoval, R. P. Linke, and Y. Matzner, "Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states, " Current Opinion in Hematology, vol. 7, no. 1, pp. 64-69, 2000.
8. P. Jousilahti, V. Salomaa, V. Rasi, E. Vahtera, and T. Palosuo, "The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease-baseline findings of the PAIS project, " Atherosclerosis, vol. 156, no. 2, pp. 451-456, 2001.
9. B. D. Johnson, K. E. Kip, and O. C. Marroquin, "Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored women?s ischemia syndrome evaluation (WISE), " Circulation, vol. 109, no. 6, pp. 726-732, 2004.
10. R. Badolato, J. M. Wang, W. J. Murphy, et al., "Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes, " Journal of ExperimentalMedicine, vol. 180, no. 1, pp. 203-209, 1994.
11. S. Hayat, and J. G. Raynes, "Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral bloodmononuclear cells and an endothelial cell line, " Scandinavian Journal of Immunology, vol. 51, no. 2, pp. 141-146, 2000.
12. X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen, "Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells, " American Journal of Physiology - Heart and Circulatory Physiology, vol. 295, no. 6, pp. H2399-H2408, 2008.
13. B. M. Schreiber, M. Veverbrants, R. E. Fine, et al., "Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis, " Biochemical Journal, vol. 344, no. 1, pp. 7-13, 1999.
14. L. G. Pessolano Jr., C. P. Sullivan, S. E. Seidl, et al., "Trafficking of endogenous smooth muscle cell cholesterol a role for serum amyloid a and interleukin-1, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 11, pp. 2741-2750, 2012.
15. L.-H. Dong, J.-K. Wen, G. Liu, et al., "Blockade of the rasextracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 683-691, 2010.
16. S. Chen, B. Liu, D. Kong, et al., "Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway, " PLoS ONE, vol. 10, no. 4, Article ID e0122577, 2015.
17. Q.-F. Ouyang, Y. Han, Z.-H. Lin, H. Xie, C.-S. Xu, and L.-D. Xie, "Fluvastatin upregulates the 1C subunit of CaV1.2 channel expression in vascular smooth muscle cells via RhoA and ERK/p38 MAPK pathways, " Disease Markers, vol. 2014, Article ID 237067, 2014.
18. B. Li, Z. Dong, H. Liu, et al., "Serum amyloid A stimulates lipoprotein-Associated phospholipase A2 expression in vitro and in vivo, " Atherosclerosis, vol. 228, no. 2, pp. 370-379, 2013.
19. S. V. Siegmund, M. Schlosser, F. A. Schildberg, et al., "Serum amyloid a induces inflammation, proliferation and cell death in activated hepatic stellate cells, " PLoS ONE, vol. 11, no. 3, Article ID e0150893, 2016.
20. R. E. Clempus, D. Sorescu, A. E. Dikalova, et al., "Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 42-48, 2007.
21. G. M. d?Eril, A. Anesi, M. Maggiore, and V. Leoni, "Biological variation of serum amyloid A in healthy subjects, " Clinical Chemistry, vol. 47, no. 8, pp. 1498-1499.
22. E. Zouridakis, P. Avanzas, R. Arroyo-Espliguero, S. Fredericks, and J. C. Kaski, "Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris, " Circulation, vol. 110, no. 13, pp. 1747-1753, 2004.
23. K. Belmokhtar, T. Robert, J. Ortillon, et al., "Signaling of serum amyloid a through receptor for advanced glycation end products as a possible mechanism for uremia-related atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 5, pp. 800-809, 2016.
24. V. J. Dzau, R. C. Braun-Dullaeus, and D. G. Sedding, "Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies, " Nature Medicine, vol. 8, no. 11, pp. 1249-1256, 2002.
25. S. Sandri, E. Hatanaka, A. G. Franco, A. M. C. Pedrosa, H. P. Monteiro, and A. Campa, "Serum amyloid A induces CCL20 secretion inmononuclear cells throughMAPK (p38 and ERK1/2) signaling pathways, " Immunology Letters, vol. 121, no. 1, pp. 22-26, 2008.
26. M. Lv, Y.-F. Xia, B. Li, et al., "Serum amyloid A stimulates vascular endothelial growth factor receptor 2 expression and angiogenesis, " Journal of Physiology and Biochemistry, vol. 72, no. 1, pp. 71-81, 2016.
27. M. Y. Zhu, Y. Wang, and F. L. Peng, "[Serum amyloid A promotes the inflammatory response via p38-MAPK/SR-BI pathway in THP-1 macrophages], " Sheng Li Xue Bao, vol. 68, no. 3, pp. 293-300, 2016.